We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current 0J4V market cap is 4.7B. The company's latest EPS is USD -0.7367 and P/E is -4.94.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 145.97M | 88.64M | 86.35M | 107.67M | 127.04M |
| Operating Income | -210.69M | -228.16M | -217.83M | -177.55M | -110.62M |
| Net Income | -204.75M | -227.28M | -220.68M | -184.91M | -110.56M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 512.78M | 353.56M | 305.71M | 250.95M | 222.51M |
| Total Liabilities | 108.95M | 117.06M | 228.14M | 237.38M | 256.48M |
| Total Equity | 403.84M | 236.49M | 77.57M | 13.57M | -33.97M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -124.58M | -184.82M | -203.35M | -146.91M | -58.79M |
| Investing | -21.78M | 208.96M | 32.73M | -3.32M | 18M |
| Financing | 186.43M | 9.11M | 156.03M | 75.06M | 54.11M |
| Market Cap | 4.7B |
| Price to Earnings Ratio | -4.94 |
| Price to Sales Ratio | 4.3 |
| Price to Cash Ratio | 19.05 |
| Price to Book Ratio | -16.08 |
| Dividend Yield | - |
| Shares Outstanding | 150.07M |
| Average Volume (1 week) | 2.61k |
| Average Volume (1 Month) | 3.74k |
| 52 Week Change | 0.00% |
| 52 Week High | 31.30 |
| 52 Week Low | 31.30 |
| Spread (Intraday) | 0 (0%) |
| Company Name | Heron Therapeutics Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.herontx.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
